Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CFBK
CFBK logo

CFBK Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy CF Bankshares Inc (CFBK) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
30.000
1 Day change
0.44%
52 Week Range
34.340
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CF Bankshares Inc (CFBK) does not present a compelling buy opportunity for a beginner, long-term investor with $50,000-$100,000 available for investment. While the technical indicators show some bullish signs, the lack of strong positive catalysts, recent analyst downgrades, and absence of significant trading trends suggest a neutral stance. Additionally, the stock's projected short-term performance is negative, and there are no recent influential trades or news to support a strong buy decision.

Technical Analysis

The MACD is positive and contracting, RSI is neutral at 51.896, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading below the pivot level of 30.257, with key support at 29.186 and resistance at 31.329. This indicates limited upward momentum in the short term.

Positive Catalysts

  • The company's turnaround story and above-peer organic balance sheet growth outlook are highlighted by analysts. The stock is also trading at a relative discounted valuation.

Neutral/Negative Catalysts

  • The recent analyst downgrade due to mixed quarterly performance, including an increase in non-performing loans and EPS shortfall, raises concerns. Additionally, the stock's projected short-term performance is negative, and there are no recent news or significant trading trends to support a positive outlook.

Financial Performance

No financial data available for the latest quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Piper Sandler maintains an Overweight rating but lowered the price target from $34 to $33.50, citing mixed quarterly performance. Previously, the firm highlighted the company's turnaround story and growth potential.

Wall Street analysts forecast CFBK stock price to rise
Analyst Rating
0
Wall Street analysts forecast CFBK stock price to rise
Buy
Hold
Sell
0
Current: 29.870
sliders
Low
0
Averages
0
High
0
0
Current: 29.870
sliders
Low
0
Averages
0
High
0
Piper Sandler
Adam Kroll
Overweight
downgrade
$34
AI Analysis
2026-05-11
Reason
Piper Sandler
Adam Kroll
Price Target
$34
AI Analysis
2026-05-11
downgrade
Overweight
Reason
Piper Sandler analyst Adam Kroll lowered the firm's price target on CF Bankshares to $33.50 from $34 and keeps an Overweight rating on the shares. The firm says the company delivered a mixed quarter, as an increase in NPLs tied to one non-core relationship resulted in $0.5M of interest reversals and drove the PPNR / EPS shortfall.
Piper Sandler
NULL
to
Overweight
initiated
$29 -> $34
2026-04-02
Reason
Piper Sandler
Price Target
$29 -> $34
2026-04-02
initiated
NULL
to
Overweight
Reason
Piper Sandler assumed coverage of CF Bankshares with an Overweight rating with a price target of $34, up from $29. The company's turnaround story has been nothing short of impressive following its recapitalization in 2012, the firm says. Piper highlights CF's above-peer organic balance sheet growth outlook, the net interest margin that should see modest expansion and drive further profitability improvement to at-least peer levels, and its relative discounted valuation.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CFBK
Unlock Now

People Also Watch